SPP1 and prostate cancer: Notably, osteopontin levels exhibit an increasing trend in cell lines that represent the continuum of prostate cancer progression (from androgen sensitive to CRPC) and correlate with a higher Gleason score, reduced survival [130], and metastatic tendencies [53,131].